What is a stock summary page? Click here for an overview.
Business Description
Kura Oncology Inc
NAICS : 325414
SIC : 2836
ISIN : US50127T1097
Compare
Compare
Traded in other countries / regions
KURA.USAKUR.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2015-08-25Description
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 43.84 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -0.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -0.3 | |||||
| 3-Year EPS without NRI Growth Rate | -0.8 | |||||
| 3-Year Book Growth Rate | -11.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 4.28 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 82.27 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.36 | |||||
| 9-Day RSI | 25.57 | |||||
| 14-Day RSI | 30.46 | |||||
| 3-1 Month Momentum % | -16.95 | |||||
| 6-1 Month Momentum % | -60.12 | |||||
| 12-1 Month Momentum % | -64.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.46 | |||||
| Quick Ratio | 9.46 | |||||
| Cash Ratio | 9.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.5 | |||||
| Shareholder Yield % | -30.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -358.55 | |||||
| Net Margin % | -322.89 | |||||
| FCF Margin % | 248.4 | |||||
| ROE % | -39.44 | |||||
| ROA % | -31.55 | |||||
| ROIC % | -560.61 | |||||
| 3-Year ROIIC % | -161.91 | |||||
| ROC (Joel Greenblatt) % | -2124.97 | |||||
| ROCE % | -33.57 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 4.56 | |||||
| PS Ratio | 9.53 | |||||
| PB Ratio | 1.11 | |||||
| Price-to-Tangible-Book | 1.11 | |||||
| Price-to-Free-Cash-Flow | 3.89 | |||||
| Price-to-Operating-Cash-Flow | 3.88 | |||||
| EV-to-EBIT | 1.24 | |||||
| EV-to-Forward-EBIT | -0.6 | |||||
| EV-to-EBITDA | 1.25 | |||||
| EV-to-Forward-EBITDA | -0.6 | |||||
| EV-to-Revenue | -3.93 | |||||
| EV-to-Forward-Revenue | 6.21 | |||||
| EV-to-FCF | -1.58 | |||||
| Price-to-Net-Current-Asset-Value | 1.16 | |||||
| Price-to-Net-Cash | 1.21 | |||||
| Earnings Yield (Greenblatt) % | 80.65 | |||||
| FCF Yield % | 28.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KURA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kura Oncology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 53.883 | ||
| EPS (TTM) ($) | -2.03 | ||
| Beta | 0.43 | ||
| 3-Year Sharpe Ratio | -0.16 | ||
| 3-Year Sortino Ratio | -0.26 | ||
| Volatility % | 38.45 | ||
| 14-Day RSI | 30.46 | ||
| 14-Day ATR ($) | 0.427378 | ||
| 20-Day SMA ($) | 7.18 | ||
| 12-1 Month Momentum % | -64.36 | ||
| 52-Week Range ($) | 5.82 - 23.48 | ||
| Shares Outstanding (Mil) | 80.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kura Oncology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kura Oncology Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kura Oncology Inc Frequently Asked Questions
What is Kura Oncology Inc(KURA)'s stock price today?
The current price of KURA is $5.90. The 52 week high of KURA is $23.48 and 52 week low is $5.82.
When is next earnings date of Kura Oncology Inc(KURA)?
The next earnings date of Kura Oncology Inc(KURA) is 2025-05-02 Est..
Does Kura Oncology Inc(KURA) pay dividends? If so, how much?
Kura Oncology Inc(KURA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers